Backeljauw, P
Semaglutide is used for long-term weight maintenance sustained weekly injections prevent the metabolic adaptation and appetite rebound that cause regain in patients who have lost weight through other methods
For your safety, semaglutide is not recommended for individuals with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
The weight-loss effects of Semaglutide, a long-acting GLP-1RA, are well-established,9 and this was confirmed in our elderly cohort
Typically, if my patients wish to taper off Ozempic, we will reduce the dose every 2-4 weeks, depending on side effects and appetite, until they are off the medication, she says
Management of hyperglycaemia in type 2 diabetes, 2022